FDA recall D-0749-2022

DASH Pharmaceuticals LLC · Class II · drug

Product

Sucralfate Oral Suspension, USP 1g/10mL, packaged in a) 40 case of 10 mL unit Dose Cups (NDC 69339-148-17) and b) 100 case of 10 mL Unit Dose Cups (NDC 69339-148-19) Rx Only, Dash Pharmaceuticals, Upper Saddle River, NJ 07458.

Reason for recall

Labeling: Label Mix-Up

Distribution

Nationwide within the United States

Key facts

Status
Terminated
Initiation date
2022-03-11
Report date
2022-04-13
Termination date
2023-02-16
Voluntary/Mandated
Voluntary: Firm initiated
Location
Upper Saddle River, NJ, United States

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0749-2022